nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilotinib—CA6—saliva—celiac disease	0.0193	0.0417	CbGeAlD
Nilotinib—UGT1A1—urine—celiac disease	0.0112	0.0241	CbGeAlD
Nilotinib—CA9—gall bladder—celiac disease	0.00744	0.0161	CbGeAlD
Nilotinib—CDC42BPB—smooth muscle tissue—celiac disease	0.0063	0.0136	CbGeAlD
Nilotinib—MAPK8—connective tissue—celiac disease	0.00623	0.0135	CbGeAlD
Nilotinib—FRK—lymphoid tissue—celiac disease	0.00597	0.0129	CbGeAlD
Nilotinib—PDGFRA—gall bladder—celiac disease	0.00597	0.0129	CbGeAlD
Nilotinib—MAPK8—epithelium—celiac disease	0.00591	0.0128	CbGeAlD
Nilotinib—BLK—lymphoid tissue—celiac disease	0.00576	0.0124	CbGeAlD
Nilotinib—LYN—connective tissue—celiac disease	0.00575	0.0124	CbGeAlD
Nilotinib—MAPK8—smooth muscle tissue—celiac disease	0.0057	0.0123	CbGeAlD
Nilotinib—EPHB2—lymphoid tissue—celiac disease	0.0057	0.0123	CbGeAlD
Nilotinib—EPHB2—digestive system—celiac disease	0.00563	0.0122	CbGeAlD
Nilotinib—BLK—blood—celiac disease	0.00542	0.0117	CbGeAlD
Nilotinib—MAPK8—pancreas—celiac disease	0.00527	0.0114	CbGeAlD
Nilotinib—TIE1—epithelium—celiac disease	0.00513	0.0111	CbGeAlD
Nilotinib—CDC42BPB—digestive system—celiac disease	0.00497	0.0107	CbGeAlD
Nilotinib—TIE1—smooth muscle tissue—celiac disease	0.00494	0.0107	CbGeAlD
Nilotinib—KIT—gall bladder—celiac disease	0.00477	0.0103	CbGeAlD
Nilotinib—CYP2C9—urine—celiac disease	0.00469	0.0101	CbGeAlD
Nilotinib—PDGFRB—gall bladder—celiac disease	0.00466	0.0101	CbGeAlD
Nilotinib—MAPK8—lymphoid tissue—celiac disease	0.00455	0.00984	CbGeAlD
Nilotinib—MAPK8—digestive system—celiac disease	0.0045	0.00972	CbGeAlD
Nilotinib—FRK—liver—celiac disease	0.00439	0.00949	CbGeAlD
Nilotinib—MAPK8—blood—celiac disease	0.00429	0.00926	CbGeAlD
Nilotinib—CA3—connective tissue—celiac disease	0.00424	0.00915	CbGeAlD
Nilotinib—LYN—lymphoid tissue—celiac disease	0.0042	0.00908	CbGeAlD
Nilotinib—MAP4K1—lymphoid tissue—celiac disease	0.00414	0.00894	CbGeAlD
Nilotinib—MAPK14—connective tissue—celiac disease	0.00396	0.00854	CbGeAlD
Nilotinib—LYN—blood—celiac disease	0.00396	0.00854	CbGeAlD
Nilotinib—MAP4K1—blood—celiac disease	0.0039	0.00841	CbGeAlD
Nilotinib—MAPK14—epithelium—celiac disease	0.00376	0.00811	CbGeAlD
Nilotinib—EPHB4—connective tissue—celiac disease	0.00375	0.0081	CbGeAlD
Nilotinib—EPHB3—digestive system—celiac disease	0.00371	0.00801	CbGeAlD
Nilotinib—CDC42BPB—liver—celiac disease	0.00371	0.008	CbGeAlD
Nilotinib—MAPK14—smooth muscle tissue—celiac disease	0.00362	0.00782	CbGeAlD
Nilotinib—TEK—connective tissue—celiac disease	0.00359	0.00775	CbGeAlD
Nilotinib—CYP3A4—urine—celiac disease	0.00358	0.00773	CbGeAlD
Nilotinib—BRAF—blood—celiac disease	0.00356	0.00769	CbGeAlD
Nilotinib—EPHB4—epithelium—celiac disease	0.00356	0.00769	CbGeAlD
Nilotinib—CYP2D6—urine—celiac disease	0.00352	0.0076	CbGeAlD
Nilotinib—EPHA2—epithelium—celiac disease	0.00349	0.00754	CbGeAlD
Nilotinib—HCK—lymphoid tissue—celiac disease	0.00345	0.00745	CbGeAlD
Nilotinib—EPHB4—smooth muscle tissue—celiac disease	0.00343	0.00741	CbGeAlD
Nilotinib—HCK—digestive system—celiac disease	0.00341	0.00736	CbGeAlD
Nilotinib—TEK—epithelium—celiac disease	0.00341	0.00736	CbGeAlD
Nilotinib—MAPK8—liver—celiac disease	0.00335	0.00724	CbGeAlD
Nilotinib—CA7—digestive system—celiac disease	0.00334	0.00721	CbGeAlD
Nilotinib—TEK—smooth muscle tissue—celiac disease	0.00328	0.00709	CbGeAlD
Nilotinib—PDGFRA—connective tissue—celiac disease	0.00325	0.00702	CbGeAlD
Nilotinib—HCK—blood—celiac disease	0.00325	0.00702	CbGeAlD
Nilotinib—ABL2—blood—celiac disease	0.00323	0.00697	CbGeAlD
Nilotinib—EPHB4—pancreas—celiac disease	0.00317	0.00685	CbGeAlD
Nilotinib—EPHA2—pancreas—celiac disease	0.00311	0.00672	CbGeAlD
Nilotinib—LYN—liver—celiac disease	0.00309	0.00668	CbGeAlD
Nilotinib—TEK—pancreas—celiac disease	0.00303	0.00656	CbGeAlD
Nilotinib—CA12—connective tissue—celiac disease	0.003	0.00648	CbGeAlD
Nilotinib—PDGFRA—smooth muscle tissue—celiac disease	0.00297	0.00642	CbGeAlD
Nilotinib—EPHA4—blood—celiac disease	0.00295	0.00638	CbGeAlD
Nilotinib—CA9—digestive system—celiac disease	0.00293	0.00633	CbGeAlD
Nilotinib—TIE1—liver—celiac disease	0.00291	0.00628	CbGeAlD
Nilotinib—MAPK14—lymphoid tissue—celiac disease	0.00289	0.00625	CbGeAlD
Nilotinib—FGR—lymphoid tissue—celiac disease	0.00288	0.00622	CbGeAlD
Nilotinib—CSF1R—connective tissue—celiac disease	0.00286	0.00618	CbGeAlD
Nilotinib—MAPK14—digestive system—celiac disease	0.00286	0.00617	CbGeAlD
Nilotinib—FGR—digestive system—celiac disease	0.00285	0.00615	CbGeAlD
Nilotinib—CA2—gall bladder—celiac disease	0.00283	0.00611	CbGeAlD
Nilotinib—BRAF—liver—celiac disease	0.00279	0.00602	CbGeAlD
Nilotinib—MAPK14—blood—celiac disease	0.00272	0.00588	CbGeAlD
Nilotinib—FGR—blood—celiac disease	0.00271	0.00585	CbGeAlD
Nilotinib—LCK—blood—celiac disease	0.00271	0.00585	CbGeAlD
Nilotinib—EPHB4—digestive system—celiac disease	0.00271	0.00585	CbGeAlD
Nilotinib—EPHA2—lymphoid tissue—celiac disease	0.00269	0.00581	CbGeAlD
Nilotinib—EPHA2—digestive system—celiac disease	0.00266	0.00574	CbGeAlD
Nilotinib—TEK—lymphoid tissue—celiac disease	0.00262	0.00567	CbGeAlD
Nilotinib—CSF1R—smooth muscle tissue—celiac disease	0.00262	0.00566	CbGeAlD
Nilotinib—KIT—connective tissue—celiac disease	0.0026	0.00561	CbGeAlD
Nilotinib—EPHB4—blood—celiac disease	0.00258	0.00557	CbGeAlD
Nilotinib—HCK—liver—celiac disease	0.00254	0.00549	CbGeAlD
Nilotinib—PDGFRB—connective tissue—celiac disease	0.00254	0.00548	CbGeAlD
Nilotinib—EPHA2—blood—celiac disease	0.00253	0.00547	CbGeAlD
Nilotinib—ABL2—liver—celiac disease	0.00252	0.00545	CbGeAlD
Nilotinib—TEK—blood—celiac disease	0.00247	0.00533	CbGeAlD
Nilotinib—KIT—epithelium—celiac disease	0.00247	0.00533	CbGeAlD
Nilotinib—PDGFRB—epithelium—celiac disease	0.00241	0.00521	CbGeAlD
Nilotinib—KIT—smooth muscle tissue—celiac disease	0.00238	0.00514	CbGeAlD
Nilotinib—PDGFRA—lymphoid tissue—celiac disease	0.00238	0.00513	CbGeAlD
Nilotinib—EPHB6—blood—celiac disease	0.00236	0.0051	CbGeAlD
Nilotinib—PDGFRA—digestive system—celiac disease	0.00235	0.00507	CbGeAlD
Nilotinib—PDGFRB—smooth muscle tissue—celiac disease	0.00232	0.00502	CbGeAlD
Nilotinib—CA3—liver—celiac disease	0.00228	0.00492	CbGeAlD
Nilotinib—ABL1—connective tissue—celiac disease	0.00226	0.00489	CbGeAlD
Nilotinib—UGT1A1—digestive system—celiac disease	0.00224	0.00484	CbGeAlD
Nilotinib—PDGFRA—blood—celiac disease	0.00224	0.00483	CbGeAlD
Nilotinib—KIT—pancreas—celiac disease	0.0022	0.00475	CbGeAlD
Nilotinib—CA12—digestive system—celiac disease	0.00217	0.00468	CbGeAlD
Nilotinib—PDGFRB—pancreas—celiac disease	0.00215	0.00464	CbGeAlD
Nilotinib—UGT1A1—blood—celiac disease	0.00213	0.00461	CbGeAlD
Nilotinib—MAPK14—liver—celiac disease	0.00213	0.0046	CbGeAlD
Nilotinib—FGR—liver—celiac disease	0.00212	0.00458	CbGeAlD
Nilotinib—LCK—liver—celiac disease	0.00212	0.00458	CbGeAlD
Nilotinib—CSF1R—lymphoid tissue—celiac disease	0.00209	0.00452	CbGeAlD
Nilotinib—CA14—liver—celiac disease	0.00207	0.00447	CbGeAlD
Nilotinib—ABL1—smooth muscle tissue—celiac disease	0.00207	0.00447	CbGeAlD
Nilotinib—CSF1R—digestive system—celiac disease	0.00207	0.00447	CbGeAlD
Nilotinib—MAP2K5—blood—celiac disease	0.00202	0.00436	CbGeAlD
Nilotinib—EPHB4—liver—celiac disease	0.00202	0.00436	CbGeAlD
Nilotinib—CA1—pancreas—celiac disease	0.00201	0.00434	CbGeAlD
Nilotinib—EPHA2—liver—celiac disease	0.00198	0.00428	CbGeAlD
Nilotinib—CSF1R—blood—celiac disease	0.00197	0.00425	CbGeAlD
Nilotinib—TEK—liver—celiac disease	0.00193	0.00417	CbGeAlD
Nilotinib—ABL1—pancreas—celiac disease	0.00191	0.00413	CbGeAlD
Nilotinib—KIT—lymphoid tissue—celiac disease	0.0019	0.0041	CbGeAlD
Nilotinib—KIT—digestive system—celiac disease	0.00188	0.00405	CbGeAlD
Nilotinib—PDGFRB—lymphoid tissue—celiac disease	0.00186	0.00401	CbGeAlD
Nilotinib—PDGFRB—digestive system—celiac disease	0.00183	0.00396	CbGeAlD
Nilotinib—KIT—blood—celiac disease	0.00179	0.00386	CbGeAlD
Nilotinib—PDGFRA—liver—celiac disease	0.00175	0.00378	CbGeAlD
Nilotinib—PDGFRB—blood—celiac disease	0.00175	0.00377	CbGeAlD
Nilotinib—CA1—lymphoid tissue—celiac disease	0.00174	0.00375	CbGeAlD
Nilotinib—CA1—digestive system—celiac disease	0.00172	0.00371	CbGeAlD
Nilotinib—UGT1A1—liver—celiac disease	0.00167	0.0036	CbGeAlD
Nilotinib—ABL1—lymphoid tissue—celiac disease	0.00165	0.00357	CbGeAlD
Nilotinib—CA1—blood—celiac disease	0.00164	0.00353	CbGeAlD
Nilotinib—ABL1—digestive system—celiac disease	0.00163	0.00353	CbGeAlD
Nilotinib—MAP2K5—liver—celiac disease	0.00158	0.00341	CbGeAlD
Nilotinib—ABL1—blood—celiac disease	0.00156	0.00336	CbGeAlD
Nilotinib—CA2—connective tissue—celiac disease	0.00154	0.00333	CbGeAlD
Nilotinib—CSF1R—liver—celiac disease	0.00154	0.00333	CbGeAlD
Nilotinib—CA2—epithelium—celiac disease	0.00146	0.00316	CbGeAlD
Nilotinib—CA2—smooth muscle tissue—celiac disease	0.00141	0.00304	CbGeAlD
Nilotinib—KIT—liver—celiac disease	0.0014	0.00302	CbGeAlD
Nilotinib—PDGFRB—liver—celiac disease	0.00137	0.00295	CbGeAlD
Nilotinib—CA4—digestive system—celiac disease	0.00134	0.0029	CbGeAlD
Nilotinib—CA2—pancreas—celiac disease	0.0013	0.00281	CbGeAlD
Nilotinib—CA1—liver—celiac disease	0.00128	0.00276	CbGeAlD
Nilotinib—CA4—blood—celiac disease	0.00128	0.00276	CbGeAlD
Nilotinib—ABL1—liver—celiac disease	0.00122	0.00263	CbGeAlD
Nilotinib—CA2—lymphoid tissue—celiac disease	0.00113	0.00243	CbGeAlD
Nilotinib—CA2—digestive system—celiac disease	0.00111	0.0024	CbGeAlD
Nilotinib—CA2—blood—celiac disease	0.00106	0.00229	CbGeAlD
Nilotinib—CYP2C8—blood—celiac disease	0.00101	0.00218	CbGeAlD
Nilotinib—ABCG2—blood—celiac disease	0.000982	0.00212	CbGeAlD
Nilotinib—CYP2B6—lymphoid tissue—celiac disease	0.000962	0.00208	CbGeAlD
Nilotinib—CYP2B6—digestive system—celiac disease	0.000951	0.00205	CbGeAlD
Nilotinib—CYP2C9—digestive system—celiac disease	0.000941	0.00203	CbGeAlD
Nilotinib—CYP2B6—blood—celiac disease	0.000906	0.00196	CbGeAlD
Nilotinib—CYP2C9—blood—celiac disease	0.000897	0.00194	CbGeAlD
Nilotinib—CA2—liver—celiac disease	0.000829	0.00179	CbGeAlD
Nilotinib—CYP2C8—liver—celiac disease	0.00079	0.00171	CbGeAlD
Nilotinib—ABCG2—liver—celiac disease	0.000768	0.00166	CbGeAlD
Nilotinib—CYP3A4—digestive system—celiac disease	0.000718	0.00155	CbGeAlD
Nilotinib—CYP2B6—liver—celiac disease	0.000708	0.00153	CbGeAlD
Nilotinib—CYP2D6—digestive system—celiac disease	0.000706	0.00153	CbGeAlD
Nilotinib—CYP2C9—liver—celiac disease	0.000701	0.00151	CbGeAlD
Nilotinib—CYP3A4—blood—celiac disease	0.000684	0.00148	CbGeAlD
Nilotinib—CYP2D6—blood—celiac disease	0.000673	0.00145	CbGeAlD
Nilotinib—ABCB1—epithelium—celiac disease	0.000668	0.00144	CbGeAlD
Nilotinib—ABCB1—pancreas—celiac disease	0.000595	0.00129	CbGeAlD
Nilotinib—CYP3A4—liver—celiac disease	0.000535	0.00116	CbGeAlD
Nilotinib—CYP2D6—liver—celiac disease	0.000526	0.00114	CbGeAlD
Nilotinib—ABCB1—lymphoid tissue—celiac disease	0.000514	0.00111	CbGeAlD
Nilotinib—ABCB1—digestive system—celiac disease	0.000508	0.0011	CbGeAlD
Nilotinib—ABCB1—blood—celiac disease	0.000484	0.00105	CbGeAlD
Nilotinib—ABCB1—liver—celiac disease	0.000379	0.000818	CbGeAlD
Nilotinib—MAPK8—Signaling Pathways—CCR4—celiac disease	0.000134	0.000249	CbGpPWpGaD
Nilotinib—KIT—Adaptive Immune System—HLA-DQB1—celiac disease	0.000134	0.000249	CbGpPWpGaD
Nilotinib—HCK—Immune System—HLA-DQA1—celiac disease	0.000133	0.000248	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—TAGAP—celiac disease	0.000133	0.000247	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—MYO9B—celiac disease	0.000132	0.000246	CbGpPWpGaD
Nilotinib—PDGFRB—Adaptive Immune System—CD79A—celiac disease	0.000132	0.000246	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—PTPN2—celiac disease	0.000132	0.000246	CbGpPWpGaD
Nilotinib—BLK—Immune System—CD79A—celiac disease	0.000131	0.000244	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—CD79A—celiac disease	0.000131	0.000244	CbGpPWpGaD
Nilotinib—BLK—Adaptive Immune System—CD80—celiac disease	0.000131	0.000244	CbGpPWpGaD
Nilotinib—FGR—Immune System—CD79A—celiac disease	0.00013	0.000243	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—MBL2—celiac disease	0.00013	0.000242	CbGpPWpGaD
Nilotinib—LYN—Adaptive Immune System—CD79A—celiac disease	0.000129	0.000241	CbGpPWpGaD
Nilotinib—LCK—Cytokine Signaling in Immune system—HLA-DRB1—celiac disease	0.000129	0.000241	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—CCR4—celiac disease	0.000127	0.000237	CbGpPWpGaD
Nilotinib—PDGFRA—Adaptive Immune System—HLA-DQB1—celiac disease	0.000127	0.000236	CbGpPWpGaD
Nilotinib—KIT—Adaptive Immune System—CD8A—celiac disease	0.000125	0.000233	CbGpPWpGaD
Nilotinib—HCK—Immune System—HLA-DQB1—celiac disease	0.000125	0.000232	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—RGS1—celiac disease	0.000124	0.000232	CbGpPWpGaD
Nilotinib—KIT—Immune System—FCGR2A—celiac disease	0.000124	0.000231	CbGpPWpGaD
Nilotinib—PDGFRB—Adaptive Immune System—HLA-DQA1—celiac disease	0.000122	0.000227	CbGpPWpGaD
Nilotinib—KIT—Immune System—TNFAIP3—celiac disease	0.000122	0.000227	CbGpPWpGaD
Nilotinib—BLK—Immune System—HLA-DQA1—celiac disease	0.000121	0.000225	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—HLA-DQA1—celiac disease	0.000121	0.000225	CbGpPWpGaD
Nilotinib—FGR—Immune System—HLA-DQA1—celiac disease	0.00012	0.000224	CbGpPWpGaD
Nilotinib—LYN—Adaptive Immune System—HLA-DQA1—celiac disease	0.000119	0.000222	CbGpPWpGaD
Nilotinib—KIT—Immune System—PTPN2—celiac disease	0.000119	0.000221	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—LCT—celiac disease	0.000119	0.000221	CbGpPWpGaD
Nilotinib—PDGFRA—Adaptive Immune System—CD8A—celiac disease	0.000118	0.00022	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—RGS1—celiac disease	0.000118	0.000219	CbGpPWpGaD
Nilotinib—LCK—Signaling by NGF—CD80—celiac disease	0.000117	0.000219	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—FCGR2A—celiac disease	0.000117	0.000219	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—HLA-DPB1—celiac disease	0.000117	0.000218	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—MBL2—celiac disease	0.000117	0.000218	CbGpPWpGaD
Nilotinib—HCK—Immune System—CD8A—celiac disease	0.000116	0.000217	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—HLA-DPB1—celiac disease	0.000115	0.000215	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—TNFAIP3—celiac disease	0.000115	0.000215	CbGpPWpGaD
Nilotinib—HCK—Innate Immune System—CD4—celiac disease	0.000115	0.000214	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—TAGAP—celiac disease	0.000115	0.000213	CbGpPWpGaD
Nilotinib—LYN—Immune System—MBL2—celiac disease	0.000115	0.000213	CbGpPWpGaD
Nilotinib—PDGFRB—Adaptive Immune System—HLA-DQB1—celiac disease	0.000114	0.000212	CbGpPWpGaD
Nilotinib—ABL1—Immune System—MBL2—celiac disease	0.000114	0.000212	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—CCR3—celiac disease	0.000114	0.000212	CbGpPWpGaD
Nilotinib—BLK—Immune System—HLA-DQB1—celiac disease	0.000113	0.00021	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—HLA-DQB1—celiac disease	0.000113	0.00021	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—PTPN2—celiac disease	0.000113	0.00021	CbGpPWpGaD
Nilotinib—FGR—Immune System—HLA-DQB1—celiac disease	0.000113	0.00021	CbGpPWpGaD
Nilotinib—LCK—HIV Infection—CD4—celiac disease	0.000112	0.000209	CbGpPWpGaD
Nilotinib—LYN—Adaptive Immune System—HLA-DQB1—celiac disease	0.000112	0.000208	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—CTLA4—celiac disease	0.000111	0.000207	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—SH2B3—celiac disease	0.000111	0.000207	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—CTLA4—celiac disease	0.000109	0.000204	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—MBL2—celiac disease	0.000109	0.000202	CbGpPWpGaD
Nilotinib—MAPK11—Innate Immune System—CD80—celiac disease	0.000109	0.000202	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—CCR3—celiac disease	0.000108	0.000202	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—CCR4—celiac disease	0.000107	0.000199	CbGpPWpGaD
Nilotinib—PDGFRB—Adaptive Immune System—CD8A—celiac disease	0.000107	0.000198	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—RGS1—celiac disease	0.000106	0.000198	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—CD79A—celiac disease	0.000106	0.000198	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—FCGR2A—celiac disease	0.000106	0.000197	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—CCR4—celiac disease	0.000106	0.000197	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—CD8A—celiac disease	0.000105	0.000196	CbGpPWpGaD
Nilotinib—BLK—Immune System—CD8A—celiac disease	0.000105	0.000196	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—SH2B3—celiac disease	0.000105	0.000196	CbGpPWpGaD
Nilotinib—FGR—Immune System—CD8A—celiac disease	0.000105	0.000196	CbGpPWpGaD
Nilotinib—LYN—Adaptive Immune System—CD8A—celiac disease	0.000104	0.000194	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—CD79A—celiac disease	0.000104	0.000194	CbGpPWpGaD
Nilotinib—MAPK8—Innate Immune System—CD4—celiac disease	0.000104	0.000194	CbGpPWpGaD
Nilotinib—KIT—Immune System—HLA-DPB1—celiac disease	0.000104	0.000194	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—RGS1—celiac disease	0.000104	0.000194	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—TNFAIP3—celiac disease	0.000104	0.000193	CbGpPWpGaD
Nilotinib—FGR—Innate Immune System—CD4—celiac disease	0.000104	0.000193	CbGpPWpGaD
Nilotinib—LYN—Immune System—FCGR2A—celiac disease	0.000104	0.000193	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—LCT—celiac disease	0.000104	0.000193	CbGpPWpGaD
Nilotinib—ABL1—Immune System—FCGR2A—celiac disease	0.000103	0.000192	CbGpPWpGaD
Nilotinib—KIT—Adaptive Immune System—HLA-DRB1—celiac disease	0.000102	0.000189	CbGpPWpGaD
Nilotinib—LYN—Immune System—TNFAIP3—celiac disease	0.000102	0.000189	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—PTPN2—celiac disease	0.000101	0.000189	CbGpPWpGaD
Nilotinib—ABL1—Immune System—TNFAIP3—celiac disease	0.000101	0.000188	CbGpPWpGaD
Nilotinib—BLK—Adaptive Immune System—CD4—celiac disease	9.99e-05	0.000186	CbGpPWpGaD
Nilotinib—LYN—Immune System—PTPN2—celiac disease	9.93e-05	0.000185	CbGpPWpGaD
Nilotinib—ABL1—Immune System—PTPN2—celiac disease	9.88e-05	0.000184	CbGpPWpGaD
Nilotinib—KIT—Immune System—CTLA4—celiac disease	9.86e-05	0.000184	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—RGS1—celiac disease	9.85e-05	0.000183	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—HLA-DPB1—celiac disease	9.84e-05	0.000183	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—FCGR2A—celiac disease	9.82e-05	0.000183	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—HLA-DQA1—celiac disease	9.79e-05	0.000182	CbGpPWpGaD
Nilotinib—KIT—Innate Immune System—CD80—celiac disease	9.79e-05	0.000182	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—LCT—celiac disease	9.76e-05	0.000182	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—LCT—celiac disease	9.68e-05	0.00018	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—TNFAIP3—celiac disease	9.64e-05	0.000179	CbGpPWpGaD
Nilotinib—PDGFRA—Adaptive Immune System—HLA-DRB1—celiac disease	9.63e-05	0.000179	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—HLA-DQA1—celiac disease	9.62e-05	0.000179	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—CCR4—celiac disease	9.62e-05	0.000179	CbGpPWpGaD
Nilotinib—HCK—Immune System—HLA-DRB1—celiac disease	9.48e-05	0.000177	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—PTPN2—celiac disease	9.41e-05	0.000175	CbGpPWpGaD
Nilotinib—KIT—Immune System—CD79A—celiac disease	9.4e-05	0.000175	CbGpPWpGaD
Nilotinib—KIT—Adaptive Immune System—CD80—celiac disease	9.4e-05	0.000175	CbGpPWpGaD
Nilotinib—LCK—Immune System—MBL2—celiac disease	9.39e-05	0.000175	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—CTLA4—celiac disease	9.33e-05	0.000174	CbGpPWpGaD
Nilotinib—PDGFRA—Innate Immune System—CD80—celiac disease	9.27e-05	0.000173	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—HLA-DQB1—celiac disease	9.16e-05	0.000171	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—CCR4—celiac disease	9.11e-05	0.00017	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—CCR3—celiac disease	9.07e-05	0.000169	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—HLA-DQB1—celiac disease	9e-05	0.000168	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—CCR3—celiac disease	8.99e-05	0.000167	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—CD79A—celiac disease	8.9e-05	0.000166	CbGpPWpGaD
Nilotinib—PDGFRA—Adaptive Immune System—CD80—celiac disease	8.9e-05	0.000166	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—HLA-DPB1—celiac disease	8.87e-05	0.000165	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—SH2B3—celiac disease	8.84e-05	0.000165	CbGpPWpGaD
Nilotinib—HCK—Immune System—CD80—celiac disease	8.76e-05	0.000163	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—SH2B3—celiac disease	8.76e-05	0.000163	CbGpPWpGaD
Nilotinib—LYN—Immune System—HLA-DPB1—celiac disease	8.68e-05	0.000162	CbGpPWpGaD
Nilotinib—KIT—Immune System—HLA-DQA1—celiac disease	8.68e-05	0.000162	CbGpPWpGaD
Nilotinib—PDGFRB—Adaptive Immune System—HLA-DRB1—celiac disease	8.68e-05	0.000162	CbGpPWpGaD
Nilotinib—ABL1—Immune System—HLA-DPB1—celiac disease	8.64e-05	0.000161	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—HLA-DRB1—celiac disease	8.59e-05	0.00016	CbGpPWpGaD
Nilotinib—BLK—Immune System—HLA-DRB1—celiac disease	8.59e-05	0.00016	CbGpPWpGaD
Nilotinib—FGR—Immune System—HLA-DRB1—celiac disease	8.56e-05	0.000159	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—CD8A—celiac disease	8.55e-05	0.000159	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—RGS1—celiac disease	8.52e-05	0.000159	CbGpPWpGaD
Nilotinib—LYN—Adaptive Immune System—HLA-DRB1—celiac disease	8.5e-05	0.000158	CbGpPWpGaD
Nilotinib—LCK—Immune System—FCGR2A—celiac disease	8.49e-05	0.000158	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—CD8A—celiac disease	8.41e-05	0.000157	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—CTLA4—celiac disease	8.41e-05	0.000157	CbGpPWpGaD
Nilotinib—PDGFRB—Innate Immune System—CD80—celiac disease	8.35e-05	0.000155	CbGpPWpGaD
Nilotinib—LCK—Immune System—TNFAIP3—celiac disease	8.33e-05	0.000155	CbGpPWpGaD
Nilotinib—MAPK11—Innate Immune System—CD4—celiac disease	8.29e-05	0.000154	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—HLA-DPB1—celiac disease	8.23e-05	0.000153	CbGpPWpGaD
Nilotinib—LYN—Immune System—CTLA4—celiac disease	8.23e-05	0.000153	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—HLA-DQA1—celiac disease	8.21e-05	0.000153	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—CCR4—celiac disease	8.2e-05	0.000153	CbGpPWpGaD
Nilotinib—ABL1—Immune System—CTLA4—celiac disease	8.19e-05	0.000153	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—CCR3—celiac disease	8.18e-05	0.000152	CbGpPWpGaD
Nilotinib—LYN—Innate Immune System—CD80—celiac disease	8.17e-05	0.000152	CbGpPWpGaD
Nilotinib—LCK—Immune System—PTPN2—celiac disease	8.14e-05	0.000152	CbGpPWpGaD
Nilotinib—ABL1—Innate Immune System—CD80—celiac disease	8.14e-05	0.000151	CbGpPWpGaD
Nilotinib—KIT—Immune System—HLA-DQB1—celiac disease	8.12e-05	0.000151	CbGpPWpGaD
Nilotinib—HCK—Disease—CD80—celiac disease	8.09e-05	0.000151	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—CCR4—celiac disease	8.03e-05	0.00015	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—CD79A—celiac disease	8.02e-05	0.000149	CbGpPWpGaD
Nilotinib—PDGFRB—Adaptive Immune System—CD80—celiac disease	8.02e-05	0.000149	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—SH2B3—celiac disease	7.97e-05	0.000148	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—CD80—celiac disease	7.94e-05	0.000148	CbGpPWpGaD
Nilotinib—BLK—Immune System—CD80—celiac disease	7.94e-05	0.000148	CbGpPWpGaD
Nilotinib—FGR—Immune System—CD80—celiac disease	7.91e-05	0.000147	CbGpPWpGaD
Nilotinib—LYN—Immune System—CD79A—celiac disease	7.85e-05	0.000146	CbGpPWpGaD
Nilotinib—LYN—Adaptive Immune System—CD80—celiac disease	7.85e-05	0.000146	CbGpPWpGaD
Nilotinib—ABL1—Immune System—CD79A—celiac disease	7.81e-05	0.000146	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—CTLA4—celiac disease	7.8e-05	0.000145	CbGpPWpGaD
Nilotinib—MAPK14—Innate Immune System—CD80—celiac disease	7.75e-05	0.000144	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—CCR3—celiac disease	7.74e-05	0.000144	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—HLA-DQB1—celiac disease	7.68e-05	0.000143	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—CCR4—celiac disease	7.61e-05	0.000142	CbGpPWpGaD
Nilotinib—KIT—Immune System—CD8A—celiac disease	7.58e-05	0.000141	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—SH2B3—celiac disease	7.55e-05	0.000141	CbGpPWpGaD
Nilotinib—KIT—Innate Immune System—CD4—celiac disease	7.47e-05	0.000139	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—CD79A—celiac disease	7.44e-05	0.000139	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—HLA-DQA1—celiac disease	7.4e-05	0.000138	CbGpPWpGaD
Nilotinib—LYN—Immune System—HLA-DQA1—celiac disease	7.24e-05	0.000135	CbGpPWpGaD
Nilotinib—ABL1—Immune System—HLA-DQA1—celiac disease	7.21e-05	0.000134	CbGpPWpGaD
Nilotinib—KIT—Adaptive Immune System—CD4—celiac disease	7.18e-05	0.000134	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—CD8A—celiac disease	7.17e-05	0.000134	CbGpPWpGaD
Nilotinib—LCK—Immune System—HLA-DPB1—celiac disease	7.12e-05	0.000132	CbGpPWpGaD
Nilotinib—PDGFRA—Innate Immune System—CD4—celiac disease	7.07e-05	0.000132	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—CCR3—celiac disease	6.98e-05	0.00013	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—HLA-DRB1—celiac disease	6.96e-05	0.00013	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—HLA-DQB1—celiac disease	6.92e-05	0.000129	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—HLA-DQA1—celiac disease	6.87e-05	0.000128	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—HLA-DRB1—celiac disease	6.84e-05	0.000127	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—CCR3—celiac disease	6.83e-05	0.000127	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—SH2B3—celiac disease	6.8e-05	0.000127	CbGpPWpGaD
Nilotinib—PDGFRA—Adaptive Immune System—CD4—celiac disease	6.79e-05	0.000126	CbGpPWpGaD
Nilotinib—LYN—Immune System—HLA-DQB1—celiac disease	6.78e-05	0.000126	CbGpPWpGaD
Nilotinib—ABL1—Immune System—HLA-DQB1—celiac disease	6.75e-05	0.000126	CbGpPWpGaD
Nilotinib—LCK—Immune System—CTLA4—celiac disease	6.75e-05	0.000126	CbGpPWpGaD
Nilotinib—LCK—Innate Immune System—CD80—celiac disease	6.7e-05	0.000125	CbGpPWpGaD
Nilotinib—HCK—Immune System—CD4—celiac disease	6.69e-05	0.000125	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—SH2B3—celiac disease	6.66e-05	0.000124	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—CCR4—celiac disease	6.58e-05	0.000123	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—CCR3—celiac disease	6.47e-05	0.000121	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—CD8A—celiac disease	6.46e-05	0.00012	CbGpPWpGaD
Nilotinib—LCK—Immune System—CD79A—celiac disease	6.43e-05	0.00012	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—CD80—celiac disease	6.43e-05	0.00012	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—HLA-DQB1—celiac disease	6.42e-05	0.00012	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—LCT—celiac disease	6.38e-05	0.000119	CbGpPWpGaD
Nilotinib—PDGFRB—Innate Immune System—CD4—celiac disease	6.37e-05	0.000119	CbGpPWpGaD
Nilotinib—LYN—Immune System—CD8A—celiac disease	6.33e-05	0.000118	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—CD80—celiac disease	6.32e-05	0.000118	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—SH2B3—celiac disease	6.31e-05	0.000117	CbGpPWpGaD
Nilotinib—ABL1—Immune System—CD8A—celiac disease	6.3e-05	0.000117	CbGpPWpGaD
Nilotinib—LYN—Innate Immune System—CD4—celiac disease	6.24e-05	0.000116	CbGpPWpGaD
Nilotinib—ABL1—Innate Immune System—CD4—celiac disease	6.21e-05	0.000116	CbGpPWpGaD
Nilotinib—HCK—Disease—CD4—celiac disease	6.17e-05	0.000115	CbGpPWpGaD
Nilotinib—KIT—Immune System—HLA-DRB1—celiac disease	6.17e-05	0.000115	CbGpPWpGaD
Nilotinib—PDGFRB—Adaptive Immune System—CD4—celiac disease	6.12e-05	0.000114	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—CD4—celiac disease	6.06e-05	0.000113	CbGpPWpGaD
Nilotinib—BLK—Immune System—CD4—celiac disease	6.06e-05	0.000113	CbGpPWpGaD
Nilotinib—FGR—Immune System—CD4—celiac disease	6.04e-05	0.000112	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—CD8A—celiac disease	6e-05	0.000112	CbGpPWpGaD
Nilotinib—LYN—Adaptive Immune System—CD4—celiac disease	5.99e-05	0.000112	CbGpPWpGaD
Nilotinib—LCK—Immune System—HLA-DQA1—celiac disease	5.94e-05	0.000111	CbGpPWpGaD
Nilotinib—MAPK14—Innate Immune System—CD4—celiac disease	5.92e-05	0.00011	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—HLA-DRB1—celiac disease	5.84e-05	0.000109	CbGpPWpGaD
Nilotinib—BRAF—Disease—CD80—celiac disease	5.78e-05	0.000108	CbGpPWpGaD
Nilotinib—KIT—Immune System—CD80—celiac disease	5.7e-05	0.000106	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—CCR3—celiac disease	5.6e-05	0.000104	CbGpPWpGaD
Nilotinib—LCK—Immune System—HLA-DQB1—celiac disease	5.55e-05	0.000103	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—SH2B3—celiac disease	5.46e-05	0.000102	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—CD80—celiac disease	5.4e-05	0.000101	CbGpPWpGaD
Nilotinib—KIT—Disease—CD80—celiac disease	5.26e-05	9.8e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—HLA-DRB1—celiac disease	5.26e-05	9.8e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—CD8A—celiac disease	5.19e-05	9.66e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—HLA-DRB1—celiac disease	5.15e-05	9.59e-05	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—CD80—celiac disease	5.13e-05	9.55e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—HLA-DRB1—celiac disease	5.13e-05	9.55e-05	CbGpPWpGaD
Nilotinib—LCK—Innate Immune System—CD4—celiac disease	5.11e-05	9.52e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—CD80—celiac disease	4.98e-05	9.28e-05	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—CD4—celiac disease	4.91e-05	9.15e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—HLA-DRB1—celiac disease	4.88e-05	9.1e-05	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—CD80—celiac disease	4.88e-05	9.08e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—CD80—celiac disease	4.86e-05	9.05e-05	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—CD4—celiac disease	4.83e-05	8.99e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—CD80—celiac disease	4.76e-05	8.86e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—CD80—celiac disease	4.74e-05	8.82e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—CD80—celiac disease	4.51e-05	8.4e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—CD80—celiac disease	4.49e-05	8.36e-05	CbGpPWpGaD
Nilotinib—BRAF—Disease—CD4—celiac disease	4.42e-05	8.22e-05	CbGpPWpGaD
Nilotinib—KIT—Immune System—CD4—celiac disease	4.35e-05	8.11e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—HLA-DRB1—celiac disease	4.22e-05	7.86e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—CD4—celiac disease	4.12e-05	7.67e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—CD80—celiac disease	4.09e-05	7.61e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—CD80—celiac disease	4.05e-05	7.54e-05	CbGpPWpGaD
Nilotinib—KIT—Disease—CD4—celiac disease	4.02e-05	7.48e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—CD80—celiac disease	3.9e-05	7.27e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—CD4—celiac disease	3.8e-05	7.08e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—CD4—celiac disease	3.71e-05	6.91e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—CD80—celiac disease	3.69e-05	6.86e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—CD4—celiac disease	3.63e-05	6.77e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—CD4—celiac disease	3.62e-05	6.74e-05	CbGpPWpGaD
Nilotinib—LCK—Disease—CD80—celiac disease	3.6e-05	6.71e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—CD80—celiac disease	3.49e-05	6.5e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—CD4—celiac disease	3.45e-05	6.42e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—CD4—celiac disease	3.43e-05	6.38e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—CD80—celiac disease	3.14e-05	5.85e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—CD80—celiac disease	3.08e-05	5.73e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—CD4—celiac disease	2.98e-05	5.55e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—CD80—celiac disease	2.92e-05	5.43e-05	CbGpPWpGaD
Nilotinib—LCK—Disease—CD4—celiac disease	2.75e-05	5.12e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—CD80—celiac disease	2.52e-05	4.7e-05	CbGpPWpGaD
